Efficacy and safety of rituximab in the treatment of primary central nervous system lymphoma: A meta-analysis and systematic review of 1,388 patients.

Rituxan (rituximab) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/42741313

Chunxing Li; Dongxiao Wang; Lichaoyue Sun; Qing Xie; Wei Chen; Wenshu Li; Zhao Ren

Sep 16, 2026